Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Titel:
Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial
Auteur:
Califano, R. Hochmair, M.J. Gridelli, C. Delmonte, A. Garcia Campelo, M.R. Bearz, A. Griesinger, F. Morabito, A. Felip, E. Ghosh, S. Tiseo, M. Haney, J. Kerstein, D. Popat, S. Camidge, D.R.